PWA
RVMD icon

Physician Wealth Advisors’s Revolution Medicines RVMD Stock Holding History

Physician Wealth Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.93K Buy
37
+25
+208% +$3.65K ﹤0.01% 981
2026
Q1 		$1.17K Buy
12
+4
+50% +$404 ﹤0.01% 1590
2025
Q4 		$638 Sell
8
-9
-53% -$590 ﹤0.01% 1768
2025
Q3 		$794 Sell
17
-14
-45% -$548 ﹤0.01% 1693
2025
Q2 		$1.14K Buy
31
+14
+82% +$538 ﹤0.01% 1312
2025
Q1 		$602 Hold
17
– – ﹤0.01% 1340
2024
Q4 		$744 Buy
+17
New +$858 ﹤0.01% 1012

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Physician Wealth Advisors's RVMD Position: Q2 2026 in Review

Physician Wealth Advisors increased its Revolution Medicines (RVMD) stake by 208% in Q2 2026, buying an estimated $3.65K and bringing the position to 37 shares worth $6.93K. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Physician Wealth Advisors first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Physician Wealth Advisors held 37 shares of Revolution Medicines worth $6.93K as of Q2 2026.
  • Physician Wealth Advisors bought 25 Revolution Medicines shares in Q2 2026, an estimated $3.65K.
  • Revolution Medicines made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #981 holding.
  • Physician Wealth Advisors first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.